Page last updated: 2024-08-17

quinoxalines and methyl-thiohydantoin-tryptophan

quinoxalines has been researched along with methyl-thiohydantoin-tryptophan in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aichler, M; Basavarajappa, D; Beck, H; Bornkamm, GW; Conrad, M; Eggenhofer, E; Esposito, I; Förster, H; Friedmann Angeli, JP; Geissler, EK; Hammond, VJ; Heinrichmeyer, M; Herbach, N; Kagan, VE; Kobayashi, S; Neff, F; O'Donnell, VB; Proneth, B; Rådmark, O; Schick, JA; Schneider, M; Seibt, T; Stockwell, BR; Thomas, SB; Tyurin, VA; Tyurina, YY; Walch, A; Wanke, R; Yefremova, O1

Other Studies

1 other study(ies) available for quinoxalines and methyl-thiohydantoin-tryptophan

ArticleYear
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice.
    Nature cell biology, 2014, Volume: 16, Issue:12

    Topics: Acute Kidney Injury; Animals; Apoptosis; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Cardiolipins; Cell Line; Glutathione Peroxidase; Humans; Imidazoles; In Situ Nick-End Labeling; Indoles; Kidney; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Peroxidases; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipid Hydroperoxide Glutathione Peroxidase; Quinoxalines; Reperfusion Injury; Spiro Compounds

2014